2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Hemoglobinuria: new trials by email Literature Review of Hemoglobinuria trials Research Report on Hemoglobinuria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. Pegcetacoplan (APL-2) in PNH Subjects. Pegcetacoplan - Paroxysmal Nocturnal Hemoglobinuria | Phase 1 | Completed | Apellis Pharmaceuticals, Inc. | 23 | 2015-12-01 | 2021-01-11 |
| A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH Pegcetacoplan - Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 1 | Completed | Apellis Pharmaceuticals, Inc. | 9 | 2015-02-23 | 2021-01-08 |
Anemia (2) · Hematologic Diseases (2) · Hemoglobinuria, Paroxysmal (2) · Hemolysis (2)
Anemia, Hemolytic (2) · Bone Marrow Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Hemic and Lymphatic Diseases (2) · Male Urogenital Diseases (2) · Myelodysplastic Syndromes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Proteinuria (2) · Signs and Symptoms (2) · Urination Disorders (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Urological Manifestations (2)
pegcetacoplan (2)
Apellis Pharmaceuticals, Inc. (2)
Hong Kong (1) · Malaysia (1) · New Zealand (1) · Thailand (1) · United States (1)